Hopes for a cancer cure rose a notch last spring when word got out that doctors were giving serious and hopeful attention to a white powder named Krebiozen (TIME, April 9)-even though the experts carefully said it was too soon to make any claims for it. Last week the A.M.A.'s Committee on Research reported its own investigation of 100 patients treated with Krebiozen: only two showed improvement even for a little while. 98 got no benefit. 44 are now dead. A.M.A. conclusion: Krebiozen is no good.
...
To continue reading:
or
Log-In
